SPECIAL EDITION BLOG: Bringing Novel Health Technologies to Market: An Important Priority for the FDA.

07.10.23

Renalytix achieves significant milestone. How does this get us one step closer to eradicating kidney disease?

07.05.23

How can reading Mark Twain illuminate how chronic kidney disease is treated today?

06.05.23

What’s the 411 on the state of kidney care in this country?

05.08.23

Why are there so many barriers to diagnosing and treating kidney disease?

04.11.23

Can Early-Stage Risk Assessment Tools be the Game-changer in Kidney Care?A quick Q&A with UCLA’s Dr. Keith Norris.

12.15.22

The Importance of Earlier-Stage Kidney Care and Why PCPs are the Key. A quick Q&A with UCLA’s Dr. Keith Norris.

12.07.22

Why we need to remove race from kidney function equations. A quick Q&A with UCLA’s Dr. Keith Norris.

11.17.22

Should race ever play a role in health care? Find out what UCLA’s Dr. Keith Norris has to say.

11.01.22

Getting FDA approval, a base hit. Getting reimbursement, that’s the ball game.

06.28.22

Is there real value in value-based care?

02.08.22

A SPECIAL, NEW YEAR INVESTIGATIVE BLOG: Making Sense of Population Health, Precision Medicine & Value-Based Care with Mount Sinai’s Dr. Arshad Rahim

01.06.22

An “Inside Look” at Precision Medicine, Cardiovascular & Kidney Disease: We Get It Straight from Bayer’s, Dr. Amit Sharma

10.26.21

A “How To” Playbook for Disrupting Kidney Care: Our Live Chat with the National Kidney Foundation’s Chief Medical Officer

09.20.21

Are Kidney-Focused Clinical Studies Finally Hitting Their Groove? The Trials to Watch & Why

08.10.21

3 Ways We’re Translating Lessons Learned in Cancer to Help Fix the Kidney Care Model

07.27.21

6 Tipping Point Innovations in Kidney Care: A Leading Expert Shares His POV

06.28.21

Why a Shift in Thinking from Kidney Disease to Kidney Health is Mission-Critical. A Candid Conversation with NKF Board Member, Holly Kramer

06.02.21